Approval · Notice of Compliance 8152 · 2006
ANAGRYD: Notice of Compliance 8152
Issued July 18, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8152
- Date
- July 18, 2006
- Company
- Les Laboratoires NovichemBrossard, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Platelet reducing agent
- Canadian reference product
- AGRYLIN (Shire Biochem Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANAGRYD | 02283344 | — |
Medicinal ingredients
- ANAGRELIDE HYDROCHLORIDE MONOHYDRATE 0.5 MG per CAP